Concordance Between Central Blood PRessure dEvices In Nephrology Patients

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 119 participants.

Also called NCT05963880

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 119 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05963880
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT05963880. Non-randomized; no masking; primary purpose diagnostic. Start 2021-04-26 (actual); primary completion 2024-11-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Concordance Between Central Blood PRessure dEvices In Nephrology Patients
Acronym
CBP-REIN
Condition
Hypertension
Condition
Blood Pressure
Intervention (Device)
Brachial and Central BP measurements with Mobil-o-Graph NG device (IEM), WatchBP Office device (Microlife), BP+ device (Uscom) and Oscar 2 with SphygmoCor inside device (SunTech)
Lead sponsor
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal (class: other)

Record details

Record id
cardio:ct-nct05963880
Content hash
8d0d7c5f68cd9601e154f225d203b669b51801c38bea68fc256de8c5f56722e9